Sunovion Pharmaceuticals Inc. engages in discovering, developing, and commercializing therapeutic products for patients suffering from
Business Model:
Revenue: $0
Employees: 5,001-10,000
Sunovion Pharmaceuticals was acquired by
Dainippon Sumitomo Pharma.
The acquisition happend on 2009-09-03.
Details of the transaction were not public
Address:
City: Marlborough
State: Massachusetts
Zip:
Country: United States
Sunovion Pharmaceuticals Inc. (formerly Sepracor) engages in discovering, developing, and commercializing therapeutic products for patients suffering from central nervous system disorders, respiratory disorders, and other illnesses. Its products include LUNESTA medicine that helps people sleep better; XOPENEX levalbuterol HCl inhalation solution; and BROVANA aformoterol tartrate inhalation solution. The company&s;s products also comprise OMNARIS ciclesonide nasal spray; ALVESCO ciclesonide HFA inhalation aerosol; and LATUDA, an oral antipsychotic tablet for the treatment of schizophrenia. It offers products for the treatment of depression, epilepsy, neuropathic pain, and insomnia, as well as respiratory conditions, such as asthma, allergic rhinitis, and chronic obstructive pulmonary diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
8/2016 | Cynapsus Therapeutics | |
8/2012 | Elevation Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|